FNY Investment Advisers LLC Has $997,000 Holdings in UnitedHealth Group Incorporated $UNH

FNY Investment Advisers LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2,101.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,400 shares of the healthcare conglomerate’s stock after acquiring an additional 2,291 shares during the quarter. FNY Investment Advisers LLC’s holdings in UnitedHealth Group were worth $997,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vaughan David Investments LLC IL lifted its position in shares of UnitedHealth Group by 2.7% during the 4th quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate’s stock valued at $49,772,000 after acquiring an additional 3,934 shares during the period. Fideuram Intesa Sanpaolo Private Banking S.P.A. increased its stake in UnitedHealth Group by 1,287.2% in the first quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate’s stock valued at $16,241,000 after purchasing an additional 55,695 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of UnitedHealth Group by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate’s stock worth $30,238,162,000 after purchasing an additional 995,210 shares in the last quarter. PBCay One RSC Ltd acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $14,343,000. Finally, Sumitomo Mitsui Financial Group Inc. raised its stake in UnitedHealth Group by 8.7% during the 4th quarter. Sumitomo Mitsui Financial Group Inc. now owns 102,260 shares of the healthcare conglomerate’s stock worth $33,757,000 after buying an additional 8,226 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 2.1%

NYSE UNH opened at $403.94 on Friday. The company has a current ratio of 0.78, a quick ratio of 0.80 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $366.84 billion, a P/E ratio of 25.99, a PEG ratio of 1.43 and a beta of 0.62. The business has a fifty day simple moving average of $413.55 and a 200 day simple moving average of $350.44. UnitedHealth Group Incorporated has a 12 month low of $239.50 and a 12 month high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. During the same quarter in the prior year, the business posted $4.08 EPS. The business’s revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 19.69 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date was Monday, June 15th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Piper Sandler set a $477.00 price objective on UnitedHealth Group in a report on Thursday, July 16th. Weiss Ratings downgraded shares of UnitedHealth Group from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, July 28th. UBS Group upped their price objective on shares of UnitedHealth Group from $460.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. KeyCorp lifted their price objective on shares of UnitedHealth Group from $400.00 to $475.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. Finally, Royal Bank Of Canada upped their target price on shares of UnitedHealth Group from $463.00 to $478.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $455.92.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.